Suchergebnisse - "Coulson, Rhiannon"

PubPharm (9)

1

Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Filipe, E. | Velayuthar, S. | Philp, A. | +50

2

INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors

enthalten in: Cancer discovery | 2024

von Dietrich, C. | Trub, A. | Ahn, A. | +14

3

CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity

enthalten in: Nature cancer | 2021

von Watt, A. | Cejas, P. | DeCristo, M. | +30

CommentIn: Nat Cancer. 2021 Jan;2(1):16-17. - PMID 35121894

4

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

enthalten in: Breast cancer research : BCR | 2020

von Portman, N. | Milioli, H. | Alexandrou, S. | +13

5

Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph Nodes

enthalten in: Cancers | 2019

von Young, A. | Duarte, J. | Coulson, R. | +7

6

Non-canonical AR activity facilitates endocrine resistance in breast cancer

enthalten in: Endocrine-related cancer | 2019

von Chia, K. | Milioli, H. | Portman, N. | +11

7

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma

enthalten in: Oncotarget | 2017

von Coulson, R. | Liew, S. | Connelly, A. | +20

CommentIn: Oncotarget. 2017 Mar 21;8(12):18618-18619. - PMID 28423631

8

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

enthalten in: Cell reports | 2016

von Johnson, S. | Cruz, C. | Greifenberg, A. | +25

9

Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β

enthalten in: Endocrinology | 2014

von Lazarus, K. | Brown, K. | Young, M. | +4

1
[1]